Functions, Physical Activity and Employment for Individuals With MS: A Pilot Feasibility Study (CoreDISTp)
Innovative Follow-up Across Health Care Levels to Optimize Functions, Physical Activity and Employment for Individuals With MS: A Pilot Feasibility Study
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The study addresses core elements in the health services for individuals with MS, constituting approximately 11000 in Norway. The two-armed pilot feasibility-RCT will be performed across the MS-outpatient (MS-OP) clinic, Nordland Hospital Trust, Bodø (NLSH), and in two surrounding municipalities, including 30 employed participants who will be followed for 10-weeks. The new intervention and pathway, CoreDISTparticipation, builds on GroupCoreDIST, which is previously found effective short and long term compared to standard care. CoreDISTparticipation consists of three phases: a) at the MS-OP clinic, in addition to the regular consultations, the patient will have a structured digital conversation with the MS-nurse addressing work related issues and a session with a physiotherapist exploring possibilities for change in balance and walking; b) in the municipality, a physiotherapist will continue exploration of improvements, followed by four weeks of GroupCoreDIST for 60 minutes, 2 times per week supplemented with home exercise programs focusing on balance, walking and physical activity. The participants will have access to exercise programs on videos through an open website at Nord University to digitally support home training.
To promote participation in employment, a structured digital meeting between each patient, the MS-nurse, the patient's employer, and the physiotherapist (who leads the group trainings) will take place in phase b; followed by phase c) which include four weeks of outdoor group based exercises and physical activity led by a physiotherapist, for 60 minutes, 2 times per week supplemented with the same home exercise programs as in phase b.
Evaluation of employment and physical activity will be conducted using an evaluation form.
The control group will receive usual consultations at the MS-OP clinic, as well as a session with a physiotherapist at the MS-OP clinic, exploring possibilities for change in balance and walking. In the municipality the control group will follow standard care (their usual follow-up).
The research team will examine feasibility, preliminary between-group differences regarding balance, walking, physical activity level, health related quality of life and barriers in employment, as well as the users' experiences with participation in the CoreDISTparticipation.
Tipo de estudo
Inscrição (Antecipado)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Bodø, Noruega
- Physiotherapy department, Nordlandssykehuset HF
-
Bodø, Noruega
- Bodø Municipality
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Diagnosed with MS (Mc Donald's criteria), Expanded Disability Status Scale ≤3.5 (no disability-fully ambulatory with moderate disability), ≥18 years, being employed. By these criteria the study will include individuals most accessible for the intervention and who have the best prospects to maintain/improve balance, walking, physical activity and participation in employment.
Exclusion Criteria:
- Retired, pregnancy at enrolment, exacerbation within two weeks prior to enrolment and other serious conditions compromising balance, walking or work capacity.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: CoreDISTparticipation
a) at the MS-OP clinic, in addition to the regular consultations, the patient will have a structured digital conversation with the MS-nurse addressing work related issues and a session with a physiotherapist exploring possibilities for change in balance and walking; b) in the municipality, a physiotherapist will continue exploration of improvements, followed by four weeks of GroupCoreDIST focusing on balance, walking and physical activity and conducted in groups of 3-5 individuals with MS and led by a physiotherapist. To promote participation in employment, a structured digital meeting between each patient, the MS-nurse, the patient's employer, and the physiotherapist will take place; followed by c) four weeks of outdoor group based exercises and physical activity led by a physiotherapist, complemented with an evaluation form regarding employment and physical activity. |
CoreDISTparticipation is a thorough intervention that contains coordination of services (physiotherapy, MS-nursing and work adaptations) between the MS-OP clinic and the municipality aiming to improve function, physical activity and employment in individuals with MS.
|
|
Comparador Ativo: Standard care
The control group will receive the usual consultations at the MS-OP clinic including exploration of possibilities for change in balance and walking together with physiotherapist at the MS-OP clinic.
The control group will furthermore follow standard care (their usual follow-up) in the municipality.
|
The standard care group will follow regular consultations at the MS-outpatient clinic including a session with the physiotherapist.
Furthermore, this group will follow usual care in the municipality which might include other forms of physiotherapy or physical activity.
These will be registered.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
MS Work Difficulties Questionnaire-23
Prazo: Baseline
|
How frequently individuals with MS perceive psychological/cognitive (11 items)-, physical (8 items)- and external barriers (4 items) related to their current or most recent job, and is scored by a five point scale (best score 0).
(Recently translated to Norwegian).
|
Baseline
|
|
Six-Minutes Walk Test
Prazo: Baseline
|
Walking distance within six minutes
|
Baseline
|
|
MS Work Difficulties Questionnaire-23
Prazo: 5 weeks post-test
|
How frequently individuals with MS perceive psychological/cognitive (11 items)-, physical (8 items)- and external barriers (4 items) related to their current or most recent job, and is scored by a five point scale (best score 0).
(Recently translated to Norwegian).
|
5 weeks post-test
|
|
Six-Minutes Walk Test
Prazo: 5 weeks post-test
|
Walking distance within six minutes
|
5 weeks post-test
|
|
MS Work Difficulties Questionnaire-23
Prazo: 10 week post-test
|
How frequently individuals with MS perceive psychological/cognitive (11 items)-, physical (8 items)- and external barriers (4 items) related to their current or most recent job, and is scored by a five point scale (best score 0).
(Recently translated to Norwegian).
|
10 week post-test
|
|
Six-Minutes Walk Test
Prazo: 10 week post-test
|
Walking distance within six minutes
|
10 week post-test
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Trunk Impairment Scale Norwegian Version
Prazo: Baseline
|
Dynamic sitting balance, 6 items, top score 16.
|
Baseline
|
|
Mini Balance Evaluation Systems Test
Prazo: Baseline
|
Pro-and reactive balance, dual task and involving sit to stand, standing and walking, 14 items on a 3 point with a top score of 28
|
Baseline
|
|
Force Platform
Prazo: Baseline
|
The force platform measures control in standing: symmetry/asymmetry of weight bearing with eyes open/closed, postural sway of center of pressure, and weight transfer which all together will present an outcome for standing balance.
|
Baseline
|
|
Activity monitors outcome 1
Prazo: Baseline
|
The monitors measure Physical activity levels (inactive, light, moderate, vigorous) within 7 days
|
Baseline
|
|
Activity monitors outcome 2
Prazo: Baseline
|
The monitors measure number of steps within 7 days
|
Baseline
|
|
European Quality of Life 5-Dimension-3 Level
Prazo: Baseline
|
Self-perceived health related quality of life regarding five domains, each with three items, and a Visual Analog Scale (0-100) recording perceived health.
|
Baseline
|
|
Multiple Sclerosis Walking Scale-12
Prazo: Baseline
|
Limitations in walking due to MS on 12 items with a scale 1-5, best score 12
|
Baseline
|
|
Multiple Sclerosis Impact Scale-29
Prazo: baseline
|
Self-perceived physical (13 items) and psychological (9 items) impact due to MS on health related quality of life recorded by a five point scale (best score 29)
|
baseline
|
|
Weight
Prazo: baseline
|
Self reported weight by kilogram
|
baseline
|
|
Height
Prazo: baseline
|
Self reported height by centimetre
|
baseline
|
|
age
Prazo: baseline
|
Self reported age by years
|
baseline
|
|
Social status
Prazo: baseline
|
Self reported social status; married, cohabitant, living alone
|
baseline
|
|
Type of multiple sclerosis
Prazo: baseline
|
Self reported main types: relapsing remitting, primary progressive, secondary progressive
|
baseline
|
|
Year of diagnosis multiple sclerosis
Prazo: baseline
|
Self reported by year
|
baseline
|
|
Medications
Prazo: baseline
|
Self reported by type of medications
|
baseline
|
|
Expanded disability status scale
Prazo: baseline
|
Self reported or from journal functional status at last yearly control by a neurologist
|
baseline
|
|
Occupation
Prazo: baseline
|
Self reported
|
baseline
|
|
Percentage of work
Prazo: baseline
|
Self reported percentage of work the previous month
|
baseline
|
|
Length of education
Prazo: baseline
|
Self reported choices: elementary school; high school; bachelor; masters degree; Doctor of philosophy degree
|
baseline
|
|
Trunk Impairment Scale Norwegian Version
Prazo: 5 weeks post-test
|
Dynamic sitting balance, 6 items, top score 16.
|
5 weeks post-test
|
|
Mini Balance Evaluation Systems Test
Prazo: 5 weeks post-test
|
Pro-and reactive balance, dual task and involving sit to stand, standing and walking, 14 items on a 3 point with a top score of 28
|
5 weeks post-test
|
|
Force Platform
Prazo: 5 weeks post-test
|
The force platform measures control in standing: symmetry/asymmetry of weight bearing with eyes open/closed, postural sway of center of pressure, and weight transfer which all together will present an outcome for standing balance.
|
5 weeks post-test
|
|
Activity monitors outcome 1
Prazo: 5 weeks post-test
|
The monitors measure Physical activity levels (inactive, light, moderate, vigorous) within 7 days
|
5 weeks post-test
|
|
Activity monitors outcome 2
Prazo: 5 weeks post-test
|
The monitors measure number of steps within 7 days
|
5 weeks post-test
|
|
European Quality of Life 5-Dimension-3 Level
Prazo: 5 weeks post-test
|
Self-perceived health related quality of life regarding
|
5 weeks post-test
|
|
Multiple Sclerosis Walking Scale-12
Prazo: 5 weeks post-test
|
Limitations in walking due to MS on 12 items with a scale 1-5, best score 12
|
5 weeks post-test
|
|
Multiple Sclerosis Impact Scale-29
Prazo: 5 weeks post-test
|
Self-perceived physical (13 items) and psychological (9 items) impact due to MS on health related quality of life recorded by a five point scale (best score 29)
|
5 weeks post-test
|
|
Percentage of work
Prazo: 5 weeks post-test
|
Self reported percentage of work
|
5 weeks post-test
|
|
Trunk Impairment Scale Norwegian Version
Prazo: 10 weeks post-test
|
Dynamic sitting balance, 6 items, top score 16.
|
10 weeks post-test
|
|
Mini Balance Evaluation Systems Test
Prazo: 10 weeks post-test
|
Pro-and reactive balance, dual task and involving sit to stand, standing and walking, 14 items on a 3 point with a top score of 28
|
10 weeks post-test
|
|
Force Platform
Prazo: 10 weeks post-test
|
The force platform measures control in standing: symmetry/asymmetry of weight bearing with eyes open/closed, postural sway of center of pressure, and weight transfer which all together will present an outcome for standing balance.
|
10 weeks post-test
|
|
Activity monitors outcome 1
Prazo: 10 weeks post-test
|
The monitors measure Physical activity levels (inactive, light, moderate, vigorous) within 7 days
|
10 weeks post-test
|
|
Activity monitors outcome 2
Prazo: 10 weeks post-test
|
The monitors measure number of steps within 7 days
|
10 weeks post-test
|
|
European Quality of Life 5-Dimension-3 Level
Prazo: 10 weeks post-test
|
Self-perceived health related quality of life regarding
|
10 weeks post-test
|
|
Multiple Sclerosis Walking Scale-12
Prazo: 10 weeks post-test
|
Limitations in walking due to MS on 12 items with a scale 1-5, best score 12
|
10 weeks post-test
|
|
Multiple Sclerosis Impact Scale-29
Prazo: 10 weeks post-test
|
Self-perceived physical (13 items) and psychological (9 items) impact due to MS on health related quality of life recorded by a five point scale (best score 29)
|
10 weeks post-test
|
|
Percentage of work
Prazo: 10 weeks post-test
|
Self reported percentage of work
|
10 weeks post-test
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Diretor de estudo: Petter Oien, PhD, Nordlandssykehuset HF
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- CoreDISTparticipation
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .